News
Results from the Phase III PURPOSE 1 (NCT04994509) and PURPOSE 2 (NCT04925752) trials highlight Yeztugo’s (lenacapavir) ...
A silent shift is taking place in the world of ageing science—one that challenges long-held assumptions and spotlights a side ...
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
2h
The New Times on MSN10 things to know about effectiveness of new HIV injectable drugGlobally, an estimated 4,000 adolescent girls and young women become infected with HIV each week, with sub-Saharan Africa accounting for more than 60% of these new infections, according to the World ...
The rising median age of people around the world has the same effect, since cancer can take decades to develop and therefore ...
Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...
IN 1971 RICHARD NIXON, then America’s president, announced a “war on cancer". Just two years earlier the Apollo programme had ...
Treatment options for patients with moderately to severely active Crohn's disease have expanded in the past decade, with ...
LIKE many women, I’ve had all sorts of body hang ups – the wobbly tummy, untoned thighs and bingo wings. My lips, though, were never one of them. Even when wearing a basic lipstick, they always ...
Hot flashes are one of the most common perimenopause symptoms. Treating them may be the key to optimizing brain and heart health.
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results